Searching News Database: Neuraltus Pharmaceuticals
HSMN NewsFeed - 26 Apr 2018
Neuraltus Pharmaceuticals Reports Results from Phase 2 NP001 Study in Amyotrophic Lateral Sclerosis (ALS)
Neuraltus Pharmaceuticals Reports Results from Phase 2 NP001 Study in Amyotrophic Lateral Sclerosis (ALS)
HSMN NewsFeed - 3 Dec 2012
ImmunoCellular Therapeutics Appoints Andrew Gengos as Chief Executive Officer
ImmunoCellular Therapeutics Appoints Andrew Gengos as Chief Executive Officer